Back to Search
Start Over
Cold agglutinin disease as a new immune-related adverse event associated with anti-PD-L1s and its treatment with rituximab.
- Source :
-
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2019 Mar; Vol. 110, pp. 21-23. Date of Electronic Publication: 2019 Feb 07. - Publication Year :
- 2019
- Subjects :
- Adult
Anemia, Hemolytic, Autoimmune chemically induced
Anemia, Hemolytic, Autoimmune immunology
B7-H1 Antigen immunology
Carcinoma, Papillary drug therapy
Carcinoma, Renal Cell drug therapy
Female
Humans
Kidney Neoplasms drug therapy
Treatment Outcome
Anemia, Hemolytic, Autoimmune drug therapy
Antibodies, Monoclonal, Humanized adverse effects
Antineoplastic Agents adverse effects
Immunologic Factors therapeutic use
Rituximab therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1879-0852
- Volume :
- 110
- Database :
- MEDLINE
- Journal :
- European journal of cancer (Oxford, England : 1990)
- Publication Type :
- Report
- Accession number :
- 30739836
- Full Text :
- https://doi.org/10.1016/j.ejca.2019.01.009